Inovio Pharmaceuticals

INO

Market cap $163M

2.37 USD

-0.23

8.85%

At close Updated Dec 18, 4:00 PM EST

Pre-market

After hours

2.34

-0.03

1.27%

1 day

-8.85%

5 days

11.27%

1 month

25.4%

3 months

2.6%

6 months

21.54%

Year to date

30.22%

1 year

33.15%

5 years

-98.1%

10 years

-97.13%

About: Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Employees: 134

Healthcare Biotechnology